9 of the 12 genetically proxied classes of antihypertensive drugs were related to significant risk decrease in CAD except for alpha-adrenoceptor blockers, angiotensin II receptor antagonists, and renin inhibitors (Figure 2B, Table S6). The gene discussed is REN; the disease is coronary artery disorder.